COMMUNIQUÉS West-GlobeNewswire
-
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues
08/01/2026 -
Week 52 COACH Trial Topline Results Confirm Consistent and Durable Treatment Benefits in Children with Achondroplasia (ACH)
08/01/2026 -
Syneos Health Appoints Simon Bartle as Chief Human Resources Officer
08/01/2026 -
Valneva SE - Declaration of voting rights - December 2025
08/01/2026 -
Déclaration d'actions et de droits de vote de la société Valneva SE - décembre 2025
08/01/2026 -
MiNK Therapeutics and University of Wisconsin–Madison Announce Phase 1 Clinical Trial of Allo-iNKT Cell Therapy (AgenT-797) to Evaluate Prevention of Graft-Versus-Host Disease
08/01/2026 -
Easy Environmental Solutions Enters 2026 With Accelerated Global Momentum and a Clear Path to Scale
08/01/2026 -
Vystar Corp. Submits Binding Letter of Intent to Acquire Stake in GoPaid.com LLC and Form Strategic Partnership with Capital R3alm to Launch R3alm Oracle and R3alm Collectibles
08/01/2026 -
ALK to present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco
08/01/2026 -
ALX Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference
08/01/2026 -
LucyRx Appoints Christin Bassett as Chief Legal Officer
08/01/2026 -
Ontario Shores Launches North America’s First Recovery High School Program for Youth Mental Health
08/01/2026 -
Argobio launches Enodia with €20.7 million seed financing to advance a small molecule platform for targeted protein degradation enabled by proteomics and machine learning
08/01/2026 -
ENvue Medical to Ring the Nasdaq Opening Bell on Wednesday, January 14th, 2026
08/01/2026 -
Dewpoint Therapeutics Announces TDP-43 Condensate Modulator Development Candidate for Treatment of ALS and Related Neurodegenerative Diseases
08/01/2026 -
Apella Raises $80 Million to Transform the Hospital with Ambient AI and Computer Vision
08/01/2026 -
Recovery First Treatment Center Names Executive Director With 25 Years of Behavioral Healthcare Leadership
08/01/2026 -
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC AI INSIGHTS INITIATIVE TO OPTIMIZE TRADITIONAL CHINESE MEDICINE PORTFOLIO, ENHANCE MARKET ANALYSIS AND EXPLORE AI-SUPPORTED CLINIC DEPLOYMENT
08/01/2026 -
Akari Therapeutics to Present at the 2026 Biotech Showcase
08/01/2026
Pages